A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.

New findings from the FACEHBI study show that baseline amyloid PET scans in people with subjective cognitive decline can ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

“This decision is an important next step of our collaboration with Denali […] that aims to advance the next generation of [amyloid beta] immunotherapies for the treatment of Alzheimer’s ...

Brain tissue analysis of an animal model has revealed the potential role of immune system dysfunction in the onset and ...

SALT LAKE CITY — A new blood test used to detect the pathology of Alzheimer’s Disease has ... excited to bring a testing option, like amyloid PET (positron emission tomography) scans or ...

The drug, called trontinemab, showed in the study that it could achieve rapid and deep reductions in amyloid beta plaques in the brain, one of the characteristics of Alzheimer's. Roche said its ...

AI Helps Unravel a Cause of Alzheimer's Disease and Identify a Therapeutic Candidate Apr. 25, 2025 — A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is ...

During the fourth wave of this study, researchers examined over 11,000 adults aged 24-34. Of these, 4,507 participants underwent cognitive tests, health exams, and provided blood samples. Later ...